Purdue Pharma opioid settlement approved by more states, including Minnesota

OxyContin maker Purdue Pharma's plan to reorganize into a new entity that helps combat the U.S. opioid epidemic got a big boost as 15 states that had previously opposed the new business model now support it, including Minnesota. The new settlement terms call for Purdue to make tens of millions of internal documents public, a step several attorneys general had demanded as a way to hold the company accountable.